Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sirpa Leppä

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
The Journal of Biological Chemistry|March 9, 2002
Mitogen-activated protein kinases and activator protein 1 are required for proliferation and cardiomyocyte differentiation of P19 embryonal carcinoma cellsMinna Eriksson, Sirpa Leppä
Duodecim; Laaketieteellinen Aikakauskirja|January 14, 2015
[Prognostic factors and treatment of diffuse large cell B-cell lymphoma]Sari Riihijärvi, Sirpa Leppä
Seminars in Hematology|July 16, 2023
Blood has never been thicker: Cell-free DNA fragmentomics in the liquid biopsy toolbox of B-cell lymphomasLeo Meriranta, Esa Pitkänen, Sirpa Leppä
Duodecim; Laaketieteellinen Aikakauskirja|December 15, 2017
Clinical significance of gene defects in B-cell lymphomasAnnika Pasanen, Leo Meriranta, Sirpa Leppä
Journal of Cellular Physiology|November 18, 2006
Mitogen activated protein kinase-dependent activation of c-Jun and c-Fos is required for neuronal differentiation but not for growth and stress response in PC12 cellsMinna Eriksson, Minna Taskinen, Sirpa Leppä
Duodecim; Laaketieteellinen Aikakauskirja|December 1, 2017
HIV infection and cancerJussi Sutinen, Sirpa Leppä, Maija Tarkkanen
Cancers|August 27, 2021
Testicular Diffuse Large B-Cell Lymphoma-Clinical, Molecular, and Immunological FeaturesMarjukka Pollari, Suvi-Katri Leivonen, Sirpa Leppä
European Journal of Haematology|October 15, 2010
Male gender is an adverse prognostic factor in B-cell lymphoma patients treated with immunochemotherapySari Riihijärvi, Minna Taskinen, Mats Jerkeman, et al.
Duodecim; Laaketieteellinen Aikakauskirja|April 4, 2009
[Is lymphoma curable with antibody therapy?]Sirpa Leppä, Heidi Nyman, Marja-Liisa Karjalainen-Lindsberg
Blood|March 1, 2008
Prognostic influence of tumor-infiltrating mast cells in patients with follicular lymphoma treated with rituximab and CHOPMinna Taskinen, Marja-Liisa Karjalainen-Lindsberg, Sirpa Leppä
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
The Journal of Biological Chemistry|March 9, 2002
Mitogen-activated protein kinases and activator protein 1 are required for proliferation and cardiomyocyte differentiation of P19 embryonal carcinoma cellsMinna Eriksson, Sirpa Leppä
Duodecim; Laaketieteellinen Aikakauskirja|January 14, 2015
[Prognostic factors and treatment of diffuse large cell B-cell lymphoma]Sari Riihijärvi, Sirpa Leppä
Seminars in Hematology|July 16, 2023
Blood has never been thicker: Cell-free DNA fragmentomics in the liquid biopsy toolbox of B-cell lymphomasLeo Meriranta, Esa Pitkänen, Sirpa Leppä
Duodecim; Laaketieteellinen Aikakauskirja|December 15, 2017
Clinical significance of gene defects in B-cell lymphomasAnnika Pasanen, Leo Meriranta, Sirpa Leppä
Journal of Cellular Physiology|November 18, 2006
Mitogen activated protein kinase-dependent activation of c-Jun and c-Fos is required for neuronal differentiation but not for growth and stress response in PC12 cellsMinna Eriksson, Minna Taskinen, Sirpa Leppä
Duodecim; Laaketieteellinen Aikakauskirja|December 1, 2017
HIV infection and cancerJussi Sutinen, Sirpa Leppä, Maija Tarkkanen
Cancers|August 27, 2021
Testicular Diffuse Large B-Cell Lymphoma-Clinical, Molecular, and Immunological FeaturesMarjukka Pollari, Suvi-Katri Leivonen, Sirpa Leppä
European Journal of Haematology|October 15, 2010
Male gender is an adverse prognostic factor in B-cell lymphoma patients treated with immunochemotherapySari Riihijärvi, Minna Taskinen, Mats Jerkeman, et al.
Duodecim; Laaketieteellinen Aikakauskirja|April 4, 2009
[Is lymphoma curable with antibody therapy?]Sirpa Leppä, Heidi Nyman, Marja-Liisa Karjalainen-Lindsberg
Blood|March 1, 2008
Prognostic influence of tumor-infiltrating mast cells in patients with follicular lymphoma treated with rituximab and CHOPMinna Taskinen, Marja-Liisa Karjalainen-Lindsberg, Sirpa Leppä
Pageof 11